To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the question. [electronic resource]
Publication details: Expert review of neurotherapeutics 09 2017Description: 847-849 p. digitalISSN:- 1744-8360
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.